Colgate-Palmolive Company (NYSE:CL) agreed to acquire Physicians Care Alliance, LLC from Norwest Venture Partners on December 18, 2017. In a separate transaction, Colgate-Palmolive Company (NYSE:CL) agreed to acquire EltaMD, Inc. from Swiss American Products, Inc. on December 18, 2017. The combined purchase price for both the transactions is $730 million. Michael Larrain, Chief Executive Officer of PCA SKIN will remain as the Chief Executive Officer of PCA SKIN. The transaction is subject to customary closing conditions, including U.S. antitrust clearance and is expected to close in the first quarter of 2018. The transaction is expected to have no impact on earnings in 2018. Joshua R. Cammaker, Edward J. Lee, Damian G. Didden, Adam J. Shapiro, Jodi J. Schwartz and Tijana J. Dvornic of Wachtell, Lipton, Rosen & Katz acted as legal advisors to Colgate-Palmolive. Financo and Houlihan Lokey acted as financial advisor to PCA SKIN. Colgate-Palmolive Company (NYSE:CL) agreed to acquire Physicians Care Alliance, LLC from Norwest Venture Partners on January 4, 2018.